27
Participants
Start Date
January 9, 2018
Primary Completion Date
December 4, 2020
Study Completion Date
December 4, 2020
KRN23
The starting dose of KRN23 will be the dose used for the last administration in the preceding studies. The dose may be modified subsequently in accordance with the criteria for dose and dose adjustment.
Hokkaido University Hospital, Sapporo
Kanagawa Prefectural Hospital Organization Kanagawa Children's Medical Center, Yokohama
National University Corporation Osaka University, Suita
The University of Tokyo Hospital, Bunkyō-Ku
Toranomon Hospital, Minato-Ku
Okayama Saiseikai General Hospital, Okayama
Japan Community Health Care Organization Osaka Hospital, Osaka
Osaka City University Hospital, Osaka
Asan Medical Center, Seoul
Seoul National University hospital, Seoul
Kyowa Kirin Co., Ltd.
INDUSTRY